Cover Image

PENAPISAN VIRTUAL BERBASIS STRUKTUR DARI DATABASE BAHAN ALAM ZINC SEBAGAI INHIBITOR BRUTON TYROSINE KINASE

Show other versions (1)

ABSTRAK Bruton Tirosin kinase (BTK) memainkan peran penting dalam banyak jalur pensinyalan seluler sehingga menjadikannya target potensial dalam mengobati penyakit autoimun dan kanker. Tujuan penelitian ini adalah untuk melakukan penapisan virtual berbasis struktur terhadap database bahan alam ZIN...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fauzan Zein Muttaqin (Author), Wayan Ayu Puje Astuti (Author), La Ode Aman (Author), Ellin Febrina (Author), Aiyi Asnawi (Author)
Format:	Book
Published:	Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin, 2019-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PENAPISAN VIRTUAL BERBASIS STRUKTUR DARI DATABASE BAHAN ALAM ZINC SEBAGAI INHIBITOR BRUTON TYROSINE KINASE
by: Fauzan Zein Muttaqin, et al.
Published: (2019)

Peningkatan Potensi Anggota KWT dalam Pemanfaatan Pekarangan untuk Tanaman Obat dan Kosmetika Menggunakan Metode Tanam Vertikal di Desa Cibiru Wetan, Kabupaten Bandung
by: Widhya Aligita, et al.
Published: (2019)

Lead compound discovery using pharmacophore-based models of small-molecule metabolites from human blood as inhibitor cellular entry of SARS-CoV-2
by: Ellin Febrina, et al.
Published: (2023)

Molecular docking and molecular dynamics study of 3-hydroxybutyrate with polymers for diabetic ketoacidosis-targeted molecularly imprinted polymers
by: Aiyi Asnawi, et al.
Published: (2024)

Peningkatan Potensi Ibu Rumah Tangga Peternak Sapi Perah dalam Membuat Yoghurt di Desa Cibiru Wetan, Kabupaten Bandung, Jawa Barat
by: Aiyi Asnawi, et al.
Published: (2021)

Bruton's tyrosine kinase inhibitor associated localized extremity edema and erythema
by: Shannon Meledathu, BS, et al.
Published: (2024)

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Impairs the Vascular Development of Zebrafish Larvae
by: Kun Wang, et al.
Published: (2021)

Bruton's Tyrosine Kinase in Neutrophils Is Crucial for Host Defense against Klebsiella pneumoniae
by: Zhe Liu, et al.
Published: (2022)

Upaya Peningkatan Pemahaman Kesehatan Lingkungan melalui Pemanfaatan Sampah Plastik dari Kaleng Cat di Desa Cibiru Wetan, Kabupaten Bandung, Jawa Barat
by: Widhya Aligita, et al.
Published: (2020)

Desa Mitra dalam Budidaya Tanaman Obat Keluarga Menuju Desa Cibiru Wetan sebagai Sentra Herbal
by: Fauzan Zein Muttaqin, et al.
Published: (2018)

Molecular docking and dynamics studies of 8,9-dimethoxy ellagic acid contained in Peperomia pellucida (L.) Kunth against various diabetes mellitus receptors
by: Yasmiwar Susilawati, et al.
Published: (2024)

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor
by: Alison H. Kucharik, MD, et al.
Published: (2024)

The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review
by: Mitra Rezaei, MD, et al.
Published: (2022)

Integrative computational approaches for designing novel alpha-glucosidase inhibitors based on curculigoside A derivatives: Virtual screening, molecular docking, and molecular dynamics
by: Aiyi Asnawi, et al.
Published: (2024)

Marine Sponge Xestospongia sp.: A Promising Source for Tuberculosis Drug Development - Computational Insights into Mycobactin Biosynthesis Inhibition
by: Arfan Arfan, et al.
Published: (2024)

Design, synthesis and evaluation of a series of potential prodrugs of a Bruton's tyrosine kinase (BTK) inhibitor
by: Zhou-Peng Xiao, et al.
Published: (2023)

Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
by: Lucie Čermáková, et al.
Published: (2022)

Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases
by: Asim Najmi, et al.
Published: (2023)

Kemitraan Asosiasi Profesi Kesehatan dalam Aplikasi Metode KESET untuk Menangani Stress di Masa Pandemi Covid-19 bagi Masyarakat Desa Cibiru Wetan dan Praktisi Apoteker Kabupaten Sumedang, Jawa Barat
by: Aiyi Asnawi, et al.
Published: (2021)

METODE SPEKTROSKOPI ATR-FTIR TANDEM PCA UNTUK MENDETEKSI KOPI ROBUSTA SEBAGAI ADULTERAN DALAM SEDIAAN KOPI ARABIKA TORAJA KOMERSIAL
by: Aiyi Asnawi, et al.
Published: (2021)

METODE SPEKTROSKOPI ATR-FTIR TANDEM PCA UNTUK MENDETEKSI KOPI ROBUSTA SEBAGAI ADULTERAN DALAM SEDIAAN KOPI ARABIKA TORAJA KOMERSIAL
by: Aiyi Asnawi, et al.
Published: (2021)

COMPARING THE INCIDENCE AND RISK FACTORS ASSOCIATED WITH CORONARY ARTERY DISEASE IN PATIENTS RECEIVING BRUTON'S TYROSINE KINASE INHIBITORS
by: Niharika Baviriseaty, MD
Published: (2024)

Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants
by: Holger Scheible, et al.
Published: (2021)

HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib
by: Ziwen Lu, et al.
Published: (2022)

A comparison of DNA repair pathways to achieve a site-specific gene modification of the Bruton's tyrosine kinase gene
by: David H. Gray, et al.
Published: (2022)

Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
by: Sibel Ucpinar, et al.
Published: (2023)

Penapisan Perkembangan Anak Usia 6 Bulan - 3 Tahun dengan Uji Tapis Perkembangan Denver II
by: Robert Sinto, et al.
Published: (2016)

A case of disseminated cryptococcal disease after Bruton tyrosine kinase inhibitor therapy: A brief review in the Australian context
by: Nicholas Van Rooij, MD, et al.
Published: (2021)

QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors
by: Mourad Aloui, et al.
Published: (2024)

In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor
by: Heather Zhang, et al.
Published: (2021)

Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis
by: Timothy J. Turner, et al.
Published: (2024)

Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis
by: Liyuan Ke, et al.
Published: (2024)

HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells
by: Danjing Liu, et al.
Published: (2023)

Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia
by: Rhodes JM, et al.
Published: (2021)

ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
by: Krishnarup Ghoshdastidar, et al.
Published: (2020)

Vegetative skin lesions in patient with bruton's agammaglobulinemia
by: Cristian Fidanzi, et al.
Published: (2023)

In silico screening of Andrographis paniculata secondary metabolites as anti-diabetes mellitus through PDE9 inhibition
by: Netty Ino Ischak, et al.
Published: (2023)

Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations
by: Shanshan Gao, et al.
Published: (2020)

Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells
by: Weam Othman Elbezanti, et al.
Published: (2022)

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling
by: Felix Huth, et al.
Published: (2022)